Process for Making Tablet Using Radiofrequency and Lossy Coated Particles
Abstract
In one aspect the present invention features process for making a tablet comprising at least one pharmaceutically active agent, said method comprising the step of applying radiofrequency energy to a powder blend to sinter said powder blend into said tablet, wherein said powder blend comprises lossy coated particles and said at least one pharmaceutically active agent, wherein said lossy coated particles comprises a substrate that is at least partially coated with a lossy coating comprising at least one activator, wherein said substrate has a Q value of greater than 100 and said activator has a Q value of less than 75.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A tablet comprising sintered lossy coated particles and at least one pharmaceutically active agent, wherein said lossy coated particles comprise a substrate that is at least partially coated with a lossy coating comprising at least one activator, wherein said substrate has a Q value of greater than 100 and said activator has a Q value of less than 75 and wherein the surface of said lossy coated particle comprises said activator.
2 . A tablet of claim 1 wherein said activator has a Q value of less than 50.
3 . A tablet of claim 1 wherein said substrate has a Q value of greater than 200.
4 . A tablet of claim 1 wherein said lossy coated particles have a Q value of greater than 100.
5 . A tablet of claim 1 comprising at least 20%, by weight, of said lossy coated particles.
6 . A tablet of claim 1 wherein said tablet disintegrates in the mouth when placed on the tongue in less than about 30 seconds.
7 . A tablet of claim 1 wherein said activator is a polymer selected from the group consisting of celluloses, hydrocolloids, polymethacrylates, polyvinyls, proteins, polysaccharides, and copolymers thereof.
8 . A tablet of claim 1 wherein said activator is hydroxypropylcellulose or hydroxyethylcellulose.
9 . A tablet of claim 1 wherein said substrate comprises a starch, a sugar alcohol, or a sugar.
10 . A tablet of claim 1 wherein said substrate comprises maltitol or mannitol.
11 . A tablet of claim 1 wherein said substrate comprises said pharmaceutically active agent.
12 . A tablet of claim 1 wherein the friability at 15 drops of the tablet is less than about 5%.
13 . A tablet of claim 1 wherein said tablet further comprises a water scavenger.
14 . A tablet of claim 1 wherein said tablet further comprises a plasticizer.
15 . A tablet of claim 1 wherein said at least one pharmaceutically active agent is contained within particles separate from the lossy coated particles.
16 . A tablet of claim 1 wherein said tablet has an in vitro disintegration time of about 30 seconds or less when based on the United States Pharmacopeia USP 24 NF29.
17 . A tablet comprising sintered lossy coated particles and at least one pharmaceutically active agent, wherein said lossy coated particles comprise a substrate that is at least partially coated with a lossy coating comprising at least one activator, wherein the Q value of the activator is less than half the Q value of the substrate and said tablet has a friability at 15 drops of the tablet is less than about 5%.Join the waitlist — get patent alerts
Track US2017354606A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.